Abbott SureStep™ Multi-Drug One Step Screen Test (Urine)

Pays: Singapour

Langue: anglais

Source: HSA (Health Sciences Authority)

Disponible depuis:

UNISON COLLABORATIVE PTE. LTD.

classe:

Class B IVD

Fabriqué par:

Abbott

Domaine thérapeutique:

Clinical toxicology

indications thérapeutiques:

A rapid, one step screening test for the simultaneous, qualitative detection of multiple drugs and drug metabolites in human urine: Buprenorphine, Ketamine, Cocaine, Cotinine, Amphetamine, Marijuana (THC), Morphine, Benzodiazepines, Methamphetamine, Methylenedioxy-methamphetamine, Phencyclidine, Tricyclic Antidepressants, Barbiturates, Methadone, and Oxycodone.

Descriptif du produit:

Models: SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-124-341-a, SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-124-441-xa, SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-144-1151-xa, SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-144-1161-xa, SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-154-041-a, SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-184-661-xa, SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-184-691-xa, SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-1104-011-a, SureStep™ Multi-Drug One Step Screen Test Panel (Urine) - DOA-1114-261-xa

Date de l'autorisation:

2019-06-13